MYC and hepatocellular carcinoma: By contrast to PT, we did not observe a significant enrichment of deregulated WNT pathway genes in AT (Fig. S7B), indicating that other factors, such as progression of viral HBV and/or chronic liver disease (Chan et al., 2004), may deregulate AT‐associated MYC expression and TER pathway genes during HCC progression.